Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic.
about
World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease--an evidence-based guideline.Prevalence of rheumatic heart disease in a public school of Belo HorizonteHeart lesion after the first attack of the rheumatic Fever 22 years experience in single centre.Echo-based screening of rheumatic heart disease in children: a cost-effectiveness Markov model.Congenital mitral valve lesions : Correlation between morphology and imaging.Screening for rheumatic heart disease: quality and agreement of focused cardiac ultrasound by briefly trained health workers.The utility of handheld echocardiography for early rheumatic heart disease diagnosis: a field studyRheumatic heart disease: pilot study for a population-based evaluation of prevalence and cardiovascular outcomes among schoolchildren in Nepal.Echocardiographic screening for rheumatic heart disease-some answers, but questions remain.Rheumatic heart disease screening: Current concepts and challengesNormal echocardiographic mitral and aortic valve thickness in children.Screening for rheumatic heart disease: current approaches and controversies.Echocardiographic screening for subclinical rheumatic heart disease remains a research tool pending studies of impact on prognosis.Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease.Screening for rheumatic heart disease in Aboriginal and Torres Strait Islander children.Increasing detection of rheumatic heart disease with echocardiography.Pilot study of nurse-led rheumatic heart disease echocardiography screening in Fiji--a novel approach in a resource-poor setting.Rheumatic heart disease echocardiographic screening: approaching practical and affordable solutions.Estimating the risk of acute rheumatic fever in New Zealand by age, ethnicity and deprivation.Family acceptability of school-based echocardiographic screening for rheumatic heart disease in a high-risk population in New Zealand.Rheumatic Fever prevention program: long-term evolution and outcomes.Latent rheumatic heart disease: outcomes 2 years after echocardiographic detection.Rheumatic heart disease screening by "point-of-care" echocardiography: an acceptable alternative in resource limited settings?Screening for rheumatic heart disease: is a paradigm shift required?Screening for rheumatic heart disease: evaluation of a simplified echocardiography-based approach.Acute rheumatic fever and rheumatic heart disease.Prominent inter-scallop separations of the posterior leaflet of the mitral valve: an important cause of 'pathological' mitral regurgitation.
P2860
Q33924517-968654C1-320F-4D80-93F0-AD3A32B6E1DBQ34114928-B67A130B-DFAB-463B-9FA1-04D31D0D4662Q35262900-2B068BEA-CE46-4CDB-95AC-FC1B6EA2B00BQ35835604-FD92072D-DE58-4FC6-945E-3ACBAD1430EBQ35890656-B0A4325B-8010-4D47-9F83-3314041E4008Q35910133-5F1C7311-719E-4334-BE01-543ABDFE2ADDQ35975040-CCDBB893-FD5F-4B33-980D-888D542F530CQ36370292-DE8D4D34-5AC3-4C39-B19E-09A8522227CBQ36508528-C0DC6965-4121-429A-AAEC-1A62AB872298Q37591380-3BBCC23F-BF98-4225-B5ED-079118C1A5F8Q37728246-32C52F57-7E15-47BD-9D26-55A2CE9FA308Q38059617-4CC42AB8-753F-4BF1-A773-E43D213B5EE9Q38075817-C94B3EA5-0251-43CC-AAB3-2A233CA30FB0Q38094958-2E4537AA-0D4D-434A-858E-3B211C04FA15Q38103584-10252032-FB92-4CE6-8A4F-B21E8DF7FDC0Q38220671-F6D0A6A7-C605-40CF-B5AB-311133146119Q38413387-18F1DDF4-0BD6-4F15-88DD-6EF0C2A3C360Q38739501-023A02D4-7028-4460-9B0E-77A27EC035CBQ39677753-68B302B5-55F7-4B62-B021-C1B412F249F6Q40165932-6AF1E962-79B9-4DEE-AA87-F9BD05FFDD4DQ40172949-5F02AE62-2B04-43CC-9ED5-10D5DB8FBBBBQ40207252-742C1084-0E07-4D05-B8C0-B51BB7FD5F47Q41897974-781E020D-61E5-4A4B-86FB-F49635C4A158Q42269587-30BFFBF5-E9D5-4D52-BCFE-238B05E90C2FQ44203090-ED11DCC7-9E0A-434D-9202-0B2B7A6E1231Q47429720-8120D98A-AD46-4098-9EE4-924E08FE9A1BQ55261725-5369CC9F-B8C0-4122-A32C-8B1A5CB55B8F
P2860
Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@en
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@nl
type
label
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@en
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@nl
prefLabel
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@en
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@nl
P2093
P2860
P1476
Optimising echocardiographic s ...... ll valve disease is rheumatic.
@en
P2093
Adrian A Trenholme
Clare P O'Donnell
Diana R Lennon
Elizabeth M Wilson
John W Stirling
Nigel J Wilson
Rachel H Webb
Ross W Nicholson
Tom L Gentles
P2860
P304
P356
10.1017/S1047951111000266
P50
P577
2011-03-31T00:00:00Z